Skip to main content

Loading market ticker...

Why Did Poly Medicure Shares Slip Despite Reporting Healthy Quarterly Earnings?

Why Did Poly Medicure Shares Slip Despite Reporting Healthy Quarterly Earnings?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • Poly Medicure shares declined nearly 8% despite reporting profitable quarterly earnings numbers.
  • The stock slipped below its 21-day moving average amid rising selling pressure.
  • Traders are monitoring whether support near INR 1,263 sustains the recent correction phase.

Overview

Poly Medicure Limited (NSE: POLYMED) remained under pressure on May 27, 2026, with the stock closing near INR 1,330.30, down 7.61% for the session. The counter witnessed broad-based selling after opening near the previous close and failing to sustain higher levels during the day.

Despite reporting healthy quarterly earnings, the stock saw sharp profit booking, indicating cautious market sentiment following the recent rally phase in the counter.

Fundamental View

For the quarter ended March 2026, Poly Medicure reported standalone total income of INR 45,813.68 lakh. Profit before tax stood at INR 10,680.62 lakh, while net profit came in at INR 8,062.17 lakh. Earnings per share were reported at INR 7.95.

Although the company posted profitable quarterly numbers, the market reaction suggested traders remained cautious amid elevated volatility and broader profit-booking activity.

Technical View

POLYMED closed near INR 1,330.30 while trading below its 21-day moving average near INR 1,544.10, reflecting a weak near-term structure. Recent price action indicates the stock witnessed sharp selling after failing to hold higher trading zones.

The 14-day RSI slipped near 36.26, remaining below the neutral mark and indicating softer momentum conditions. The stock also formed a strong bearish candle during the session, highlighting continued pressure in the counter.

Key Technical Levels

On the downside, immediate support is placed near INR 1,263.79, while the next broader support zone is around INR 1,197.27. On the upside, immediate resistance is seen near INR 1,396.82, followed by a stronger resistance zone around INR 1,463.33. Sustained recovery above resistance levels could improve sentiment, while weakness below support may keep pressure intact.

Risks to Watch

  • Continued weakness below moving averages may pressure sentiment.
  • High volatility could trigger wider price swings.
  • Failure to hold support may increase downside risk.
  • Profit booking after rallies remains a key concern.

Summary

Poly Medicure shares corrected sharply despite reporting healthy quarterly earnings, as the stock witnessed profit booking and slipped below its short-term moving average. Momentum indicators currently remain weak, while RSI reflects softer trading conditions. Traders are now watching whether support near INR 1,264–1,197 stabilizes the stock, while resistance remains placed around INR 1,397–1,463 levels.

FAQs

Why did Poly Medicure shares fall despite healthy earnings?

The stock witnessed profit booking and weak momentum despite reporting profitable quarterly earnings numbers.

What are the important support levels for POLYMED stock?

Immediate support is placed near INR 1,263.79, followed by another support zone around INR 1,197.27.

What resistance levels should traders monitor now?

Resistance is placed near INR 1,396.82 and the next upside zone stands around INR 1,463.33.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.